[Advances and challenges in detection of HER2 low expression in breast cancer].

Liu, Y P; Xue, W C; Yang, W T; Bu, Hong

Liu, Y P; Xue, W C; Yang, W T; Bu, Hong.

Afiliação

Liu YP; Department of Pathology, the Fourth Hospital of Hebei Medical University, Tumor Hospital of Hebei Province, Shijiazhuang 050011, China.
Xue WC; Department of Pathology, Peking University Cancer Hospital,Beijing 100142, China.
Yang WT; Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Bu H; Department of Pathology, West China Hospital, Sichuan University, Chengdu 610041, China.

Zhonghua Bing Li Xue Za Zhi ; 51(9): 799-802, 2022 Sep 08.

Article em Zh | MEDLINE | ID: mdl-36097893

Assuntos

Neoplasias da Mama; Neoplasias da Mama/metabolismo; Feminino; Humanos; Receptor ErbB-2/genética; Receptor ErbB-2/metabolismo

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Diagnostic_studies Limite: Female / Humans Idioma: Zh Revista: Zhonghua Bing Li Xue Za Zhi Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google